Nuveen Asset Management, LLC Mannkind Corp Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 2,437,155 shares of MNKD stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,437,155

Previous 2,689,152 9.37%

Holding current value

$15.3 Million

Previous $12.2 Million 4.43%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$4.05 - $5.43 $1.02 Million - $1.37 Million	-251,997 Reduced 9.37%	2,437,155 $12.7 Million
Q1 2024 May 13, 2024	BUY	$3.25 - $5.27 $5.55 Million - $9 Million	1,708,178 Added 174.13%	2,689,152 $12.2 Million
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $1.16 Million - $1.49 Million	347,218 Added 54.79%	980,974 $3.57 Million
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.45 $59,799 - $83,352	-15,294 Reduced 2.36%	633,756 $2.62 Million
Q2 2023 Aug 14, 2023	SELL	$3.72 - $4.79 $10.9 Million - $14 Million	-2,924,970 Reduced 81.84%	649,050 $2.64 Million
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $11 Million - $15.7 Million	2,784,563 Added 352.72%	3,574,020 $14.7 Million
Q4 2022 Feb 14, 2023	SELL	$3.02 - $5.37 $2.55 Million - $4.53 Million	-843,373 Reduced 51.65%	789,457 $4.16 Million
Q3 2022 Nov 14, 2022	SELL	$2.99 - $4.35 $2.51 Million - $3.66 Million	-840,764 Reduced 33.99%	1,632,830 $5.05 Million
Q2 2022 Aug 15, 2022	BUY	$2.67 - $4.77 $91,375 - $163,243	34,223 Added 1.4%	2,473,594 $9.42 Million
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $1.9 Million - $3.24 Million	-726,969 Reduced 22.96%	2,439,371 $8.44 Million
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $2.36 Million - $3.13 Million	582,256 Added 22.53%	3,166,340 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $2.24 Million - $3.16 Million	576,489 Added 28.72%	2,584,084 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $156,500 - $236,268	43,352 Added 2.21%	2,007,595 $10.9 Million
Q1 2021 May 17, 2021	BUY	$3.14 - $6.14 $2.16 Million - $4.23 Million	688,343 Added 53.95%	1,964,243 $7.7 Million
Q4 2020 Feb 16, 2021	BUY	$1.79 - $4.04 $876,432 - $1.98 Million	489,627 Added 62.27%	1,275,900 $3.99 Million
Q3 2020 Nov 16, 2020	BUY	$1.56 - $2.08 $6,672 - $8,896	4,277 Added 0.55%	786,273 $1.48 Million
Q2 2020 Aug 14, 2020	SELL	$0.94 - $2.21 $127,464 - $299,678	-135,601 Reduced 14.78%	781,996 $1.37 Million
Q1 2020 May 14, 2020	BUY	$0.84 - $1.76 $171,938 - $360,252	204,689 Added 28.71%	917,597 $945,000
Q3 2019 Nov 14, 2019	BUY	$1.04 - $1.44 $66,522 - $92,108	63,964 Added 9.86%	712,908 $891,000
Q2 2019 Aug 15, 2019	BUY	$1.09 - $1.88 $707,348 - $1.22 Million	648,944 New	648,944 $747,000

Others Institutions Holding MNKD

# of Institutions

219

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.61B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Mannkind Corp Transaction History